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Abstract
Background: Johne's disease, a serious chronic form of enteritis in ruminants, is caused by
Mycobacterium avium subsp. paratuberculosis (MAP). As the organism is very slow-growing and
fastidious, several PCR-based methods for detection have been developed, based mainly on the
MAP-specific gene IS900. However, because this gene is similar to genes in other mycobacteria,
there is a need for sensitive and reliable methods to confirm the presence of MAP. As described
here, two new real-time PCR systems on the IS900 gene and one on the F57 gene were developed
and carefully validated on 267 strains and 56 positive clinical faecal samples.
Results: Our confirmatory PCR systems on IS900 were found sensitive and specific, only yielding
weak false positive reactions in one strain for each system. The PCR system on F57 did not elicit
any false positives and was only slightly less sensitive than our primary IS900-system. DNA from
both naturally infected and spiked faeces that tested positive with our primary system could be
confirmed with all new systems, except one low-level infected sample that tested negative with the
F57 system.
Conclusion: We recommend using the newly constructed DH3 PCR system on the F57 gene as
the primary confirmatory test for PCR positives, but should it fail due to its lower sensitivity, the
DH1 and DH2 PCR systems should be used.
Background
Paratuberculosis (Johne's disease) is caused by Mycobacte-
rium avium subsp. paratuberculosis (MAP). It is a ubiqui-
tous chronic enteric wasting disease of ruminants, though
in Sweden the disease is rare or absent, thanks to success-
ful control measures in the past. It is regarded as an exotic
disease and falls under the Swedish Epizootic Act, which
means that in an event of an outbreak, measures must be
taken promptly to combat the disease and to trace the ori-
gin of the outbreak [1,2]. When a positive case is identi-
fied, consequences for the farmer are grave and it is
usually deemed necessary to slaughter the whole herd.
In the Swedish Paratuberculosis Control Program and in
most of the Swedish surveillances undertaken to monitor
freedom from paratuberculosis, detection is based on cul-
ture. During the culture procedure, suspected colonies are
picked and identified as MAP by PCR. Other characteris-
tics of the colony isolate act to confirm the identification
made with PCR, namely acid-fast staining (acid-fast
bacilli), growth characteristics (small, slow-growing) and
dependence on mycobactin. The PCR methods generally
used to identify and detect MAP are based on IS900, an
insertion sequence considered specific for MAP [3-6].
IS900 is a 1,451 bp segment that lacks inverted terminal
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repeats and does not generate direct repeats in target DNA
[7]. It belongs to the same family of insertion sequences
as IS901, IS902, and IS1110, described in M. avium subsp.
avium, M. avium subsp. silvaticum, and M. avium subsp.
avium, respectively [8-10].
PCR based on IS900 has been used for direct detection of
MAP, without primary culture, from milk, faecal speci-
mens, semen, and human intestinal tissue [11-16]. Apart
from being the method of choice when speed is a priority,
direct PCR is also preferred when MAP is difficult or
impossible to cultivate [17].
However, as IS900-like genes have been found in other
unrelated Mycobacterium species, it is evident that the PCR
systems used for IS900 are not completely specific for
MAP [18-20]. In a recent investigation, a nested PCR on
IS900 was shown to elicit false positive reactions from sev-
eral mycobacterial strains [21]. It is therefore desirable to
use alternative PCR systems to confirm a positive IS900
PCR for MAP. This is useful when PCR identification can-
not be confirmed by conventional culture-based meth-
ods, as is the case with direct PCR and PCR identification
of growth in liquid cultures [22,23].
In the present paper, two new real-time PCR systems that
target other parts of IS900 than does our standard (pri-
mary) PCR [16], and one real-time PCR targeting the F57
gene, specific for MAP [24], were developed and evaluated
as confirming tests on strains and clinical samples, previ-
ously found positive with our standard IS900 PCR.
Results
Specificity
All MAP strains and isolates (Table 1) proved positive
with the primary PCR system and were confirmed by all
three confirmatory systems. Listed in Table 2 are a variety
of other mycobacteria, as well as a few other bacterial
strains, that were tested with all four real-time PCR sys-
tems. With the primary PCR system, strain 2333 proved
positive, as previously reported [20]. An isolate of Myco-
bacterium avium subsp. avium from a Swedish horse and a
Mycobacterium kubicae-related isolate from cat gave weak
positive reactions (i.e. high CT values) with the IS900 sys-
tems DH1 and DH2, respectively. All the other strains
tested negative. The F57 system DH3 gave no false posi-
tive reactions.
Direct PCR on faecal samples
The procedure of first detecting MAP (or noting PCR inhi-
bition) with the primary system, then confirming posi-
tives with the three other new systems, worked well with
direct PCR on clinical samples. When inhibitors were still
present, which only was the case with samples from the
External Quality Assessment (indicated in 14 of 52 sam-
ples), a dilution of the DNA or a new preparation of the
original sample would usually solve the problem and
inhibition only remained in three of the samples. Our
method could detect MAP in 27 of the 28 valid positive
samples in the 52 samples from the External Quality
Assessment. When a sample produced a positive signal
with the primary system, the same result was obtained
with the confirmatory systems. However, as shown in
Table 3, for 12 of 56 positive samples, re-runs with addi-
tional replicates had to be performed on F57 in order to
pick up the dispersed DNA, and for one culture-negative
clinical sample with weak IS900 PCR signals, DH3 failed
to confirm the presence of MAP.
MAP could be detected in the spiked faeces using the pri-
mary system at a spiking level of 104 organisms/g and
readily confirmed at the same concentration by all three
confirmatory systems without the need for re-runs.
Sensitivity on pure DNA
The IS900 systems MP, DH1, DH2 and the F57 system
DH3 yielded positive signals from DNA suspensions with
the concentrations 0.1, 0.1, 0.3 and 1 MAP genomes/μl
respectively.
Discussion
Real-time PCR is a sensitive method for detection that
eliminates the need to open the tubes when analysing the
product, a stage in other PCR techniques that often consti-
tutes a risk of cross-contamination. In particular, the sen-
sitive method nested PCR involves a great risk of
contaminating other samples when the product from its
first reaction is being transferred to the second. Real-time
Table 1: Strains of Mycobacterium avium subsp. paratuberculosis, 
tested positive with the primary and confirmatory PCR systems.




1 Deer Czech Rep.
1 Human ATCC 49164
1 Human ATCC 43015
1 Cattle NCTC 8578
1 Human Czech Rep.
1 Cattle CIP 107488
1 Cattle ATCC 19698T
5U n k n o w n V a r i o u s d
a. Sweden (13), USA (28), Denmark (12), Czech Rep. (16), 
Switzerland (1), Norway (2), Slovak Rep. (2), Argentina (2), Great 
Britain (1).
b. Norway(16), UK (1), Greece (1), New Zeeland (1).
c. Australia (1), USA (1), Faroe Islands (1), Czech Rep. (1).
d. Denmark (4), Czech Rep.(1).
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PCR minimises the risk of false positive results due to
amplicon contamination.
Another advantage of real-time PCR is that the use of
probes enhances the specificity of the reaction, as an addi-
tional match with the target DNA will be required for a
positive signal. There is, however, still a risk for false pos-
itive results due to cross-reactions and positive results
need to be confirmed.
To confirm PCR positives for MAP, one of the most exten-
sively used methods is sequencing of a part of IS900 [25-
27]. However, with current generally available technol-
ogy, sequencing may not be the most practical method. To
Table 2: Non-target strains, tested with the primary and confirmatory PCR systems.
No. of strains Species Source Origin IS900 MP IS900 DH1 IS900 DH2 F57 DH3
1M A A a Horse Sweden - + --
1 MAA Human ATCC 35718 - - - -
1 MAA Domestic fowl ATCC 25291T -- --
6M A A V a r i o u s b Variousc -- --
1 Mycobacterium species (strain 2333) Cattle Sweden + -- -
1 Mycobacterium speciesd Cat Sweden - - + -
1 Mycobacterium kansasii Human ATCC 12478T -- --
1 Mycobacterium smegmatis Cattle Great Britain - - - -
1 Mycobacterium chelonei Cattle Sweden - - - -
1 Mycobacterium fortuitum Cattle Sweden - - - -
1 Mycobacterium bovis Deer Sweden - - - -
1 Mycobacterium bovis Cattle ATCC 19210T -- --
1 Mycobacterium silvaticum Dove Sweden - - - -
1 Mycobacterium intracellulare Sparrow ATCC 35767 - - - -
1 Mycobacterium intracellulare ATCC 13950T -- --
1 Mycobacterium intracellulare Cattle ATCC 35771 - - - -
1 Mycobacterium scrofulaceum Human ATCC 19981T -- --
1 Mycobacterium gordonae Human ATCC 14470T -- --
1 Mycobacterium marinum Guppy Sweden - - - -
2 Mycobacterium marinum Dolphin Sweden - - - -
1 Mycobacterium malmoense Human CIP 105775T -- --
1 Mycobacterium celatum Human CIP 106109 - - - -
1 Mycobacterium flavescens Guinea pig CIP 104533 - - - -
1 Mycobacterium komossense Sphagnum moss CIP 105293T -- --
1 Mycobacterium marinum Saltwater fish CIP 104528T -- --
1 Mycobacterium terrae Human CIP 104321T -- --
1 Mycobacterium vaccae Cattle CIP 105934T -- --
1 Mycobacterium xenopi Toad CIP 104035T -- --
1 Mycobacterium speciese Turtle Sweden - - - -
1 Mycobacterium porcinum Swine CIP 105392 - - - -
1 Mycobacterium porcinum Bulk milk Italy - - - -
1 Mycobacterium hiberniae Soil CIP 104537 - - - -
1 Mycobacterium cookii Sphagnum moss ATCC 49103 - - - -
110 Mycobacterium species Variousf Variousg -- --
1 Staphylococcus aureus ATCC 25923 - - - -
1 Streptococcus dysgalactiae Cattle CCUG 27436 - - - -
1 Streptococcus uberis Cattle CCUG 27444 - - - -
1 Escherichia coli ATCC 25922 - - - -
1 Arcanobacter pyogenes Cattle CCUG 39326 - - - -
1 Pseudomonas aeruginosa Human CCUG 17619 - - - -
a. Mycobacterium avium subspecies avium.
b. Cat (1), Cattle (1), Deer (1), Sheep (3).
c. Sweden (3), Faroe Islands (1), Iceland (2).
d. Mycobacterium kubicae-related strain.
e. Mycobacterium nonchromogenicum-related strain.
f. Cattle (59), Sheep (23), Monkey (1), Deer (2), Buffalo (1), Horse (1), Elephant (3), Ciclide (1), Antelope (1), Alpaca (2), Environmental (1), Cell 
culture (1), Peat (1).
g. Sweden (82), Czech Republic (3), USA (11), Australia (2), Denmark (11), Great Britain (1)
T. Type strainBMC Microbiology 2006, 6:87 http://www.biomedcentral.com/1471-2180/6/87
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obtain a successful sequencing reaction, a relatively large
amount of pure amplicon is needed, which weakly
infected samples might not yield. Furthermore, sequenc-
ing is a laborious and expensive method [28], not suitable
for confirmation of numerous positive samples. The sen-
sitivity of real-time PCR makes it easy to use the original
template DNA in reactions targeting other sites on IS900
or on other genes. Only when the template contains
minute traces of MAP DNA or is slightly PCR inhibiting,
can problems arise, as discussed below.
The two systems DH1 and DH2 were selected on the basis
of minimal sequential similarity to related IS elements in
other mycobacteria, such as the IS900 equivalent in strain
2333 [20], and minimal self-complementarity. It appears
that the sequential similarity to strain 2333 predominates
among the first 450 base pairs of IS900, which is also the
area in which most of the systems suggested by the
Primer3 software are found. Most previously described
probe-based real-time PCR systems on the IS900 gene are
also located there and thus, they have little or no possibil-
ity to discriminate against 2333 [29-32]. Many potential
systems could therefore be excluded, after which DH1 and
DH2 were selected from the remaining oligos. In contrast
to IS900, F57 has no known similarities to genes on other
related organisms, which made the task of selecting suita-
ble oligos for F57 less complicated.
It may appear simpler to change the primary system to
one of the new systems, as they seem to be more specific
than the MP system, but it should be noted that it is not
certain that each of the other systems alone is entirely spe-
cific either. When using only one of the other systems,
there is instead a risk of cross-reactions with other,
unknown organisms with similarities in other parts of the
MAP genome. For example, only a limited number of
mycobacteria that do not grow at 37°C have been tested
with F57 systems. The four systems eliminate many
potential false positives by complementing each other,
covering different parts of the IS900 – or, as for the DH3,
a part of the F57 gene. However, the DH3 together with
the primary system would probably be sufficiently specific
for the routine application, where DH1 and DH2 only
need to be used if DH3 fails, as discussed below.
Previously published works on systems targeting F57 [33-
35] have reported specificity for MAP and application of
their systems on altogether 95 strains of MAP and 188
other strains. Our system DH3, targeting F57, did not pro-
duce any false positives when applied to 112 strains of
MAP and 155 other strains. It is however less sensitive
than the systems on IS900, as there are 15 to 20 copies of
IS900 in the MAP genome [3] – and specifically 17 copies
in strain K-10 [36]. This is consistent with the results of
our sensitivity tests. A suspension of 0.1 MAP genomes/μl
contains about 1.7 IS900 elements/μl. Since real-time
PCR has been reported capable of detecting a single copy
of the target gene [37-39], the successful detection of MAP
in 2 to 2.5 μl of this suspension was expected. As there is
only one single copy of F57 in the MAP genome, the tem-
plate volume had to contain at least 1 genome for success-
ful detection. In fact, at such low concentrations, the
probability of detection drops well below 100% if an
insufficient volume is tested. Use of Poisson distribution
shows a 63% theoretical probability of at least 1 genome
observed in 1 μl at a concentration of 1 genome/μl. In 2.5
μl of template, the probability of the same is 92% and
when duplicates are run, it increases to 99.3%. Similarly,
one can show that the probability of finding at least one
IS900 in duplicates of 2 μl of the above-mentioned sus-
pension (0.1 genomes/μl) is 99.9%. In reality however,
any detection system is less than optimal and an occa-
sional target copy may be lost in the process, which is why
one must expect lower probability of detection at these
low concentrations. DNA extracted from clinical samples
may be highly complex and impure and have a slightly
inhibitory effect on the PCR reaction in weak samples,
even when a positive internal control indicates that inhi-
bition should not be a problem.
In theory, the confirmatory systems could be combined
and optimized to work as one single multiplex confirma-
tory PCR. Nevertheless, the systems were kept separate, as
competition of reagents can occur in a multiplex system,
thus lowering its sensitivity [40,41].
If a clinical sample proves positive with the primary sys-
tem, yet any of the three confirmatory systems shows neg-
ative, an investigation into the cause of this divergence
Table 3: Confirmation of clinical samples of bovine faeces, positive for MAP with the primary PCR.
Samples n Confirmed* Additional 5 replicates† Additional 20 replicates‡ F57 failure§
Culture-confirmed 47 41 4 2 0
Not culture-confirmed 9 3 5 0 1
* Confirmed by all three alternative systems, using two PCR replicates.
† Confirmed by DH3 on F57, only after running 5 additional PCR replicates.
‡ Confirmed by DH3 on F57, only after running 20 additional PCR replicates.
§Confirmation with the DH3 system failed after a total of 22 PCR replicatesBMC Microbiology 2006, 6:87 http://www.biomedcentral.com/1471-2180/6/87
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must be undertaken. If the primary system elicited a
strong signal and all laboratory errors can be excluded, the
likelihood is that the result was false positive, produced by
some other mycobacterial strain. In that case, it would
probably be of interest to further investigate this strain!
The other possibility is of course that the negative system
is not sensitive to all MAP strains, in spite of our extensive
testing.
However, when the positive signal is very weak, there may
be several reasons why some of the confirmatory systems
show negative. Because the genomes are sparse and atten-
uated in weak samples, a positive signal may be the out-
come of low probability, thus impairing reproducibility.
The confirmatory systems must then be employed again,
this time using more replicates. In particular, the DH3 sys-
tem on F57 will have a very low probability of detection
at such concentrations. In rare cases, when even repeated
analyses with additional replicates yield negative results,
one will have to do without confirmation with F57 and
instead take other aspects into account when judging the
sample as true or false positive. In fact, it was notable that
the F57 system could confirm the weakest detected level
of spiked faeces (104 organisms/g) at the first attempt.
This was probably because the weaker concentration (103
organisms/g) was very close to the detection level of the
primary system. A few weak signals were yielded by the
standard PCR, but with unacceptable high CT values.
Another considered explanation for occasional failure of
any of the systems DH1-3 to confirm the primary system
was that they might be more sensitive to inhibition than
was the primary system, which contains the internal con-
trol plasmid, especially as the confirmatory systems were
developed with the use of a template volume of 2.5 μl
instead of 2 μl. However, no such difference in robustness
has yet been shown by the authors, and it is therefore
assumed that they are equally sensitive to inhibition. Ulti-
mately, when trying to confirm a positive test, one must
be certain that a weak signal in one single system is not
due to laboratory contamination.
The false reactions given by the Mycobacterium avium strain
originating from horse and the Mycobacterium kubicae-
related isolate from cat are most likely not a problem, as
they were much weaker than would be expected when
using template from a resuspended colony. A high CT
value (>30 cycles) by confirmation of a normal-sized col-
ony should alert the investigator that a cross-reaction or a
contamination might have occurred. One could even
argue that the cut-off CT value for PCR on colonies should
be lower than for direct PCR on clinical samples, which
would have made the above false positives negative. It
was, however, not lowered, since that would also increase
the risk of occasional dismissal of colonies that are very
small or partly blended with contamination flora. In con-
trast, when higher CT values are expected, as when direct
PCR is performed on clinical samples, the above strains
are unlikely to yield positive signals. But if they still do,
the remaining systems will show them to be false.
Conclusion
After validation on several mycobacterial strains and on
faecal samples, our new confirmatory systems were found
to be both sensitive and reliable. We recommend using
the DH3 PCR on the F57 gene as the primary confirma-
tory test for PCR positives, but if it fails due to its lower
sensitivity, then the DH1 and DH2 PCR systems can be
used.
Methods
Laboratory strains, growth conditions and extraction of 
genomic DNA
MAP strains were cultured for 8 weeks on modified
Löwenstein-Jensen medium with mycobactin (4 mg/l,
Allied Monitor, Fayette, MO, USA). Other mycobacterial
strains were cultured on Löwenstein-Jensen medium at
37°C for up to 6 weeks, except the strains Mycobacterium
marinum (CIP 104528) and Mycobacterium cookii (ATCC
49103), that grow at 30° but not at 37°C.
Laboratory strains and their various origins are shown in
Tables 1 and 2. The following MAP strains have defined
RFLP subtypes: strain Telford 9.2 (RFLP type S1) from R.J.
Whittington and strains 5001-1425 (RFLP type B-C12),
P1850/1/97 (A-C10), 17 (Z-C18), M211 (H-C1), 5TSD
(B-C17), 93/433 (B-C19), P1611-15 (B-C13), 4064 (B-
C1), 1038 (B-C12), 6/922 (B-C2), 6256 (D-C12), 7954
(B-C16) 25071 (B-C13), 9602 (E-C1), 9944 (E-C1), K126
(B-C17), 6042 (D-C12), M212 (B-C2), from I. Pavlik. Iso-
lates of MAP (n = 20) from Sweden have been RFLP typed
as B-C1.
Purified MAP-DNA was obtained from ATCC 19698
(American Type Culture Collection, Rockville, MD, USA)
by beadbeating with zirconia/silica beads (0.1 mm,
BioSpec Products, Inc., Bartlesville, OK, USA) and phe-
nol/chloroform extraction. However, less pure DNA for
confirmation of identity with real-time PCR was obtained
by centrifugation of resuspended MAP colonies, heat-
killed at 99°C for 10 min.
Field isolates
Single colonies, suspected to be MAP, were isolated from
faecal cultures on modified Löwenstein-Jensen medium
[42] or on Herrolds Egg Yolk medium, both supple-
mented with mycobactin (Table 1). Other mycobacterial
isolates, obtained from various sources during veterinary
routine diagnostic work at the Mycobacteria Laboratory at
SVA, had been isolated on Löwenstein-Jensen, Stone-
brink, or Middlebrook medium (Table 2). The geographi-BMC Microbiology 2006, 6:87 http://www.biomedcentral.com/1471-2180/6/87
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cal origin as well as animal host species are also given in
Table 2 and its footnotes. Two strains (Mycobacterium
marinum from guppie and one Mycobacterium species from
turtle) did not grow at 37°C, but only at lower tempera-
tures.
Direct PCR on faeces
Template DNA for direct testing with real-time PCR was
extracted from bovine faeces. The protocol involved
removal of solid material from 1.0 to 1.2 g faeces, lysing
of the bacteria by incubation in lysisbuffer with 20 μg pro-
teinase K and beadbeating with zirconia/silica beads (0.1
mm, BioSpec Products, Inc.). Purification of the lysate was
performed with a modified QIAamp protocol (QIAamp
DNA Stool Mini Kit, Qiagen). For further details, refer to
previously published work [43]. Clinical samples (107 in
total) were obtained from the Czech Republic, Denmark,
Sweden and from the USA. The latter (52 samples) were
External Quality Assessment samples (Johne's Fecal Check
Test) from National Veterinary Services, Ames, IA. Spiked
faeces was also tested. It was spiked with different dilu-
tions of dispersed MAP bacteria, washed free of excessive
free DNA and carefully quantified in a microscope as pre-
viously described [16] to avoid overestimation of the ana-
lytical sensitivity. The final concentrations of MAP in the
spiked faeces were 102 – 107 organisms/g.
Real-time PCR based on IS900 and F57
Our primary real-time PCR system used to detect MAP in
the samples was the previously described MP system [16],
which includes an internal control for indication of PCR
inhibition. When positive, the presence of MAP was con-
firmed with three newly constructed systems: two based
on IS900 and one based on the F57 gene. The free on-line
primer design software Primer3 [44] was used to find
potential primers and probes. From these, the two systems
DH1 and DH2 were selected on IS900 and DH3 on F57.
Candidate sequences were compared with other known
genes using the BLAST Sequence Analysis Tool to check
for incidental similarities. Selected oligos are listed in
Table 4.
The PCR mixture comprised 6.625 μl H2O (Sigma-
Aldrich) in the case of the primary MP system and 8.625
μl H2O in the confirmatory systems, 2.0 μl glycerol
(Sigma-Aldrich), 2.5 μl 10× PCR-buffer II (Applied Bio-
systems, Foster City, CA, USA), 5.0 μl MgCl2 (25 mmol/l,
Applied Biosystems), 2.0 μl GeneAmp® dNTP with UTP
(2.5 mmol/l dA, C, GTP, 5 mmol/l dUTP, Applied Biosys-
tems), 0.75 μl forward primer (10 pmol/μl), 0.75 μl
reverse primer (10 pmol/μl), 0.5 μl MAP-specific probe
(10 pmol/μl), 0.5 μl mimic-specific probe (10 pmol/μl)
in the case of the primary MP-system, 0.125 μl AmpliTaq
Gold® (5 U/μl, Applied Biosystems) and 0.25 μl AmpEr-
ase® (Uracil N-glycosylase, 1 U/μl, Applied Biosystems).
The addition of glycerol allowed freezing of the PCR mix-
ture. In the case of the MP system, 2 μl of template DNA
and 2 μl of mimic molecule pWIC9 (150 fg/μl) [16] were
added to each reaction tube, except for the PCR-negative
controls. In the case of the confirmatory systems, no
mimic molecule but 2.5 μl of template DNA was added.
The real-time PCR reaction was performed on a Rotor-
Gene 3000 (Corbett Research, Mortlake, Australia) with
the following program: 50°C 2 min, 95°C 10 min, repeat
95°C 15 s and 60°C 1 min, 45 times. The results were
analysed with the Rotor-Gene software versions 5 and 6
and the built-in analytical tools Dynamic Tube Normali-
sation and Slope Correction. Real-time PCR curves of nor-
malized fluorescence for FAM crossing a threshold value
of 0.01 at less than 40 cycles were considered positive, as
long as the curves had a normal and expected shape. FAM-
negative curves with a positive corresponding ROX curve
(i.e. a positive mimic signal) were considered as true neg-
atives; otherwise, inhibition was suspected. DNA
extracted directly from faeces was run in duplicates.
If a slightly infected clinical sample yielded positive
results with all systems except the DH3 on F57, additional
runs were performed; first with five replicates, then if still
negative, with 15 replicates.
Sensitivity test on pure DNA
The concentration of purified MAP-DNA was determined
with NanoDrop (Wilmington, DE, USA) and low, specific
concentrations were obtained by serial dilution. At the
lowest concentrations (less than 100 genomes per μl) the
DNA was diluted in half-multiples of ten (100.5) for better
resolution of the sensitivity measurement. Real-time PCR
was run in duplicates on DNA suspension ranging from
10-1.5 (~0.03) to 103 MAP genomes per μl with all four
PCR systems described in Table 4.
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